These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11178407)

  • 21. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A; van Straaten-van de Kappelle I; Akkermans A; Hendriksen C; van de Donk H
    Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
    Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
    Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pasteurella multocida toxin type D serological assay as an alternative to the toxin neutralisation lethality test in mice.
    Finco-Kent DL; Galvin JE; Suiter BT; Huether MJ
    Biologicals; 2001 Mar; 29(1):7-10. PubMed ID: 11482887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective role of maternal antibodies against Haemophilus parasuis infection.
    Solano-Aguilar GI; Pijoan C; Rapp-Gabrielson V; Collins J; Carvalho LF; Winkelman N
    Am J Vet Res; 1999 Jan; 60(1):81-7. PubMed ID: 9918152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.
    Lee JH; Gramer MR; Joo HS
    Can J Vet Res; 2007 Jul; 71(3):207-12. PubMed ID: 17695596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC.
    Bruderer U; Swam H; Haas B; Visser N; Brocchi E; Grazioli S; Esterhuysen JJ; Vosloo W; Forsyth M; Aggarwal N; Cox S; Armstrong R; Anderson J
    Vet Microbiol; 2004 Jul; 101(3):187-97. PubMed ID: 15223123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of vaccination against Aujeszky's disease compared with test and slaughter programme: epidemiological and economical evaluations.
    Willeberg P; Leontides L; Ewald C; Mortensen S; McInerney JP; Howe KS; Kooij D
    Acta Vet Scand Suppl; 1996; 90():25-51. PubMed ID: 8996885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of protective erysipelas antibodies in pig and mouse sera as possible alternatives to the animal challenge models currently used for potency tests.
    Beckmann R; Gyra H; Cussler K
    Dev Biol Stand; 1996; 86():326. PubMed ID: 8785966
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of oral vaccination against swine erysipelas in growing-finishing pigs in a clinically infected Slovakian pig herd.
    Friendship CR; Bilkei G
    Vet J; 2007 Jan; 173(1):219-22. PubMed ID: 16249105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-exposure prophylaxis (PEP) of rabies-infected Indian street dogs.
    Manickama R; Basheer MD; Jayakumar R
    Vaccine; 2008 Dec; 26(51):6564-8. PubMed ID: 18848596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral vaccination against swine erysipelas--field experiences in Croatia.
    Hoffmann CR; Bilkei G
    Dtsch Tierarztl Wochenschr; 2006 Jan; 113(1):13-5. PubMed ID: 16475549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cedivac-FMD can be used according to a marker vaccine principle.
    Chénard G; Selman P; Dekker A
    Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
    Wang X; Jiang P; Li Y; Jiang W; Dong X
    Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of serum responses in swine after vaccination and challenge exposure with Actinobacillus pleuropneumoniae serotype 1.
    Stine DL; Fedorka-Cray PJ; Huether MJ; Gentry MJ; Anderson GA
    Am J Vet Res; 1994 Sep; 55(9):1238-43. PubMed ID: 7802390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain.
    Busque P; Higgins R; Caya F; Quessy S
    Can J Vet Res; 1997 Oct; 61(4):275-9. PubMed ID: 9342451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guinea pig protection test as indicator of potency of oil emulsion foot-and-mouth disease vaccines.
    Black L; Pullen L; Boge A
    Res Vet Sci; 1985 Sep; 39(2):207-11. PubMed ID: 2999930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serological test methods as replacement for infection trials in piglets to test the potency of E. coli vaccines for sows (dams)].
    Krug M; Hausleitner D; Taddey R; Volkers P; Kobe B; Cussler K
    ALTEX; 2005; 22(2):111-6. PubMed ID: 15953966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of an indirect ELISA to detect antibodies against BoHV-1 in bovine and guinea-pig serum samples using ISO/IEC 17025 standards.
    Parreño V; Romera SA; Makek L; Rodriguez D; Malacari D; Maidana S; Compaired D; Combessies G; Vena MM; Garaicoechea L; Wigdorovitz A; Marangunich L; Fernandez F
    J Virol Methods; 2010 Oct; 169(1):143-53. PubMed ID: 20655331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.